نتایج جستجو برای: anti platelet

تعداد نتایج: 470767  

Journal: :archives of medical laboratory sciences 0
mohamad ali esmaili zohreh sharifi fatemeh yari

background: activated platelets shed microparticles (mps) in vivo and certainly in vitro under storage. like platelets, platelet-derived mps contribute to hemostatic and inflammatory responses. we sought to determine the interactions between platelet mps and peripheral b lymphocytes in the healthy blood circulation to propose a possible role for platelet mps in the functioning of b cells.   mat...

A series of novel 2-aminopyrimidine and 2-Substituted-4,6-diaminopyrimidine derivatives have been synthesized and their anti platelet aggregation activities were assessed against ADP and arachidonic acid- induced platelet aggregation in human plasma using light transmission aggregometry. None of the compounds showed satisfactory activity against the aggregation induced by ADP. However, satisfac...

ژورنال: کومش 2019
Ayatolahi , Abdolmajid , Hamidpour , Mohsen , Kehanpour, Nasrin, Shahmehri, Masoud, Yasini , Mahya sadat ,

Introduction: Cardiovascular disease is one of the most common diseases in the world. In this account, atherosclerosis is one of the main cause’s heart attacks. Coagulation activity of platelets plays an important role in atherosclerotic plaque formation, thrombosis formation and cardiovascular diseases. Aspirin is the most commonly drugs which used as anti-platelet function to prevent and trea...

Faranoush M, Farsinezhad A, Hemmati T, Managhchi MR, Toogeh G,

Background: Activated normal platelets undergo many biochemical and morphological changes, some of which are apoptotic. Platelet derived microparticles and shrinked platelets as hallmark of platelet activation and apoptosis disperse surfaces containing procoagulant activity around injured vessels and tissues. This study was conducted to determine microparticles formation and platelet shrinkage ...

2003
VICTORIA DOMÍNGUEZ TZIPE GOVEZENSKY GOAR GEVORKIAN CARLOS LARRALDE

Background and Objectives. The physiopathogenesis of hemorrhagic phenomena in patients with autoimmune thrombocytopenic purpura is associated with low platelet levels. In the present work the relation between thrombocytopenia and bleeding was examined. The possible participation of endothelial cells in bleeding was also investigated. Design and Methods. Immune thrombocytopenia and bleeding were...

2009
V. Kondi

Authors’ address: V. Kondi and Natalia Mitrica, Centre of Haematology, Bucarest (Rumania) In a previous study, we have shown that sera with anti-platelet antibodies from thrombocytopenic patients or those having received multiple blood transfusions – females alloimmunized by pregnancy – are able to induce inhibition of platelet aggregation [2]. The present investigation is designed to study the...

Journal: :The Journal of clinical investigation 1984
L L Leung

Thrombospondin (TSP), the major alpha-granule protein of human platelets, binds to the activated platelet surface upon platelet stimulation. TSP has hemagglutinating (lectin-like) activity and forms a specific complex with fibrinogen. Based on these observations, it was postulated that the interaction of TSP and fibrinogen on the activated platelet surface may be an important step in the platel...

2015
Eun-Ju Yang Sae-Kwang Ku Jong-Sup Bae

Purpose: Thrombosis and thromboembolic occlusions of blood vessels are a major complication in various peripheral vascular diseases. The agents for the inhibition of platelet function are recognized as key tools in the treatment of atherothrombosis. Therefore, it became a mainstay medication for a wide range of vascular diseases. Polyozellin (POZ), a major constituent of an edible mushroom Poly...

2010
Seung-Pyo Lee Jung-Won Suh Kyung Woo Park Hae-Young Lee Hyun-Jae Kang Bon-Kwon Koo In-Ho Chae Dong-Ju Choi Seung-Woon Rha Jang-Whan Bae Myeong-Chan Cho Taek-Geun Kwon Jang-Ho Bae Hyo-Soo Kim

BACKGROUND Current guidelines recommend dual anti-platelet therapy, aspirin and clopidogrel, for patients treated with drug-eluting stent for coronary heart disease. In a few small trials, addition of cilostazol on dual anti-platelet therapy (triple anti-platelet therapy) showed better late luminal loss. In the real-world unselected patients with coronary heart disease, however, the effect of c...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید